ResearcherJikei University School of MedicineNo recent work listed
Yuki Hirose
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2019: 1 paper · 2020: none · 2021: 1 paper
Papers 2
- [A case of advanced pancreatic cancer with oculomotor nerve palsy caused by herpes zoster after introduction of gemcitabine plus nab-paclitaxel]. Co-author DOI 10.11405/nisshoshi.118.86↗
- The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients. Co-author DOI 10.1007/s00280-019-03895-2↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Utako Ishimoto · 2 shared papers, 2019–2021 · strength 0.22
- Paper [A case of advanced pancreatic cancer with oculomotor nerve palsy caused by herpes zoster after introduction of gemcita… DOI 10.11405/nisshoshi.118.86↗
- Paper The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreat… DOI 10.1007/s00280-019-03895-2↗
- Kazuhiko Koike · 2 shared papers, 2019–2021 · strength 0.22
- Paper [A case of advanced pancreatic cancer with oculomotor nerve palsy caused by herpes zoster after introduction of gemcita… DOI 10.11405/nisshoshi.118.86↗
- Paper The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreat… DOI 10.1007/s00280-019-03895-2↗
- Masayuki Saruta · 2 shared papers, 2019–2021 · strength 0.22
- Paper [A case of advanced pancreatic cancer with oculomotor nerve palsy caused by herpes zoster after introduction of gemcita… DOI 10.11405/nisshoshi.118.86↗
- Paper The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreat… DOI 10.1007/s00280-019-03895-2↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.